Liposome Co Inc at its annualmeeting announced the formation of a Canadian subsidiary,Canadian Liposome Co Ltd.    It said the company cements a relationship with Universityof British Columbia researcher Pieter Cullis and his scientificgroup who are developing anti-cancer products for Liposome.    The company also said lead bankers completed Liposome'sstock offering of one mln shares on June 11 at 6.875 dlrs ashare. Liposome said it netted 7,388,750 dlrs. Reuter&#3;